| 1 |
2020 |
Outcome after heart-lung or lung transplantation in patients with Eisenmenger syndrome. |
--- |
| 2 |
2019 |
Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease. |
CHD, PAH, PAH-CHD |
| 3 |
2019 |
Eisenmenger Syndrome in Adults: Treatment Pattern and Prognostic Factors in the Advanced Pulmonary Vasodilator Era. |
CHD, CI, HR |
| 4 |
2019 |
Endocarditis and bacterial brain abscess in a young woman with a single atrium, patent ductus arteriosus, and Eisenmenger syndrome: A case report. |
CHD |
| 5 |
2019 |
Maternal and fetal outcomes in pregnancy complicated with Eisenmenger syndrome. |
ASD, PDA, PVR, VSD |
| 6 |
2019 |
Review of evidence for bosentan therapy for treatment of Eisenmenger syndrome. |
--- |
| 7 |
2019 |
Successful Implementation of Extracorporeal Membrane Oxygenation Support as a Bridge to Heart-Lung Transplantation in an Eisenmenger's Syndrome Patient With Paradoxical Coronary Embolism. |
ECMO |
| 8 |
2019 |
The impact of trisomy 21 on treatment modalities and outcome in adults with congenital heart disease in Switzerland. |
CI, HR, SACHER |
| 9 |
2019 |
Use of gestational surrogates for women with Eisenmenger syndrome: a cost-effectiveness analysis. |
QALYs |
| 10 |
2019 |
What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis. |
6MWD, AEs, CI, ERAs, FC, PAH-SDT, PDE5i, WMD |
| 11 |
2018 |
A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension. |
6MWD, ET, PAH |
| 12 |
2018 |
Atrial septal defects and pulmonary arterial hypertension. |
ASD, CHD, PAH, PH |
| 13 |
2018 |
Dental considerations and recommendations in Eisenmenger syndrome: A report of an unusual paediatric case. |
--- |
| 14 |
2018 |
Increased microvolt T-wave alternans in children and adolescents with Eisenmenger syndrome. |
MTWA |
| 15 |
2018 |
Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome. |
MPV |
| 16 |
2018 |
Successful Percutaneous Coronary Intervention with Extracorporeal Membrane Oxygenation Support after Right Coronary Artery Dissection in an Eisenmenger Syndrome Patient. |
ECMO, PCI |
| 17 |
2018 |
The Echocardiographic Characteristics and Prognostic Significance of Pericardial Effusions in Eisenmenger Syndrome. |
PAH, PE |
| 18 |
2018 |
The Effect of Endothelin Receptor Antagonists in Patients with Eisenmenger Syndrome: A Systematic Review. |
ERAs, WHO |
| 19 |
2018 |
Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension. |
CHD, Hb, PAH, PH |
| 20 |
2017 |
Anaesthetic management of breast surgery in a patient with Eisenmenger syndrome. |
--- |
| 21 |
2017 |
Brain metabolite alterations in Eisenmenger syndrome: Evaluation with MR proton spectroscopy. |
Cho |
| 22 |
2017 |
Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome-implications on survival and the role of right ventricular transverse strain. |
PAH, RV |
| 23 |
2017 |
Early Experience of Macitentan for Pulmonary Arterial Hypertension in Adult Congenital Heart Disease. |
ERA, PDE5i |
| 24 |
2017 |
Easily measurable, noninvasive, and novel finding for pulmonary hypertension: Hypertrophy of the basal segment of septomarginal trabeculation of right ventricle. |
BNP, CMR, IPAH, LGE, PAP, PASPs, PH, RV, RVFW, SMT, TR, TTE |
| 25 |
2017 |
Effects of acute oxygen supplementation on functional capacity and heart rate recovery in Eisenmenger syndrome. |
6MWT, PVR, RVFAC, TAPSE |
| 26 |
2017 |
Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome. |
6MWD, mPAP, PAH, PASP, PVR, RV, WHO |
| 27 |
2017 |
Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977-2012. |
--- |
| 28 |
2017 |
Impact of advanced medical therapy for the outcome of an adult patient with Eisenmenger syndrome. |
PAH |
| 29 |
2017 |
Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study. |
ERA, PAH-SDT, PDE5i |
| 30 |
2017 |
Past and current cause-specific mortality in Eisenmenger syndrome. |
--- |
| 31 |
2017 |
Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome. |
AT, CHD |
| 32 |
2017 |
Secundum atrial septal defect with Eisenmenger syndrome: A scarcely reported disease in Nigeria. |
ASD |
| 33 |
2016 |
Brain diffusion changes in Eisenmenger syndrome. |
ADC, FWM, LN |
| 34 |
2016 |
Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects. |
DTT |
| 35 |
2016 |
Deep sedation for dental treatment in a Down syndrome patient with Eisenmenger syndrome: A case report. |
--- |
| 36 |
2016 |
Eisenmenger syndrome and long-term survival in patients with Down syndrome and congenital heart disease. |
--- |
| 37 |
2016 |
Elevated serum HMGB1 in pulmonary arterial hypertension secondary to congenital heart disease. |
HMGB1, PAH-CHD, PVR |
| 38 |
2016 |
Pregnancy outcome in women with Eisenmenger's syndrome: a case series from west China. |
EF, PABP, PAH |
| 39 |
2016 |
Preoperative Assessment of the Impact of Positive Pressure Ventilation With Noninvasive Positive Pressure Ventilation in a Patient With Eisenmenger Syndrome: A Case Study. |
PPV |
| 40 |
2016 |
Survival and outcomes of patients with unoperated single ventricle. |
DILV, PS, SV |
| 41 |
2016 |
Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. |
CHD, PAH, RV |
| 42 |
2016 |
[Anesthetic Management of a 69-year-old Patient with Eisenmenger Syndrome for Abdominoperineal Resection]. |
--- |
| 43 |
2016 |
[Cardiac Function after Lung Transplantation of Eisenmenger Syndrome]. |
LT |
| 44 |
2015 |
Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease. |
ADMA, CHD, PAH |
| 45 |
2015 |
Clinical and Prognostic Value of Depressive Symptoms and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Eisenmenger Syndrome. |
BDI, NT-proBNP |
| 46 |
2015 |
Impaired Right, Left, or Biventricular Function and Resting Oxygen Saturation Are Associated With Mortality in Eisenmenger Syndrome: A Clinical and Cardiovascular Magnetic Resonance Study. |
CMR |
| 47 |
2015 |
Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View. |
PAH, PAH-CHD, PAH-CHD, PH |
| 48 |
2015 |
Medical treatment for an adult patient with eisenmenger syndrome. A case report. |
BNP, PAH |
| 49 |
2015 |
Perioperative Care of Children with Eisenmenger Syndrome Undergoing Non-cardiac Surgery. |
--- |
| 50 |
2015 |
Physiological differences between various types of Eisenmenger syndrome and relation to outcome. |
PAH, RV |
| 51 |
2015 |
Pulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatrics. |
PAH |
| 52 |
2015 |
Pulmonary arterial wall thickness in Eisenmenger Syndrome: Prospective, cross-sectional, controlled clinical trial. |
PAWT, RVWT |
| 53 |
2015 |
Thoracic manifestation of Eisenmenger's syndrome in adult patients: a MDCT review. |
CHD, MDCT, PAH |
| 54 |
2015 |
Update on medical treatment of patients with eisenmenger syndrome. |
PAH |
| 55 |
2014 |
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. |
PAH-CHD, SDs, SPS |
| 56 |
2014 |
Dyspnea in Eisenmenger syndrome and its amelioration by sildenafil: role of J receptors. |
cGMP |
| 57 |
2014 |
Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). |
CHD, PAH |
| 58 |
2014 |
Left ventricular mass is preserved in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. |
IPAH, IVS, LV, LVEDV, LVFW, PH |
| 59 |
2014 |
Life span of patients with Eisenmenger syndrome is not superior to that of patients with other causes of pulmonary hypertension. |
PAH, PH |
| 60 |
2014 |
Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival. |
LGE |
| 61 |
2014 |
P-wave and QT interval dispersion analysis in children with Eisenmenger syndrome. |
CHD, TAPSE |
| 62 |
2014 |
Red blood cell distribution width predicts survival in patients with Eisenmenger syndrome. |
RDW |
| 63 |
2014 |
Survey of the current status and management of Eisenmenger syndrome: a Japanese nationwide survey. |
DTT |
| 64 |
2014 |
The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. |
CHD |
| 65 |
2014 |
Transthoracic echocardiographic and cardiopulmonary exercise testing parameters in Eisenmenger's syndrome. Association with six-minute walk test distance. |
CPET, sPAP, TTE, VSD |
| 66 |
2014 |
[The management of adult female patients with Eisenmenger syndrome and advanced pulmonary arterial hypertension treatment: single center experience and follow-up for 5 years]. |
PAH |
| 67 |
2013 |
Clinical features of adult patients with Eisenmenger's syndrome in Japan and Korea. |
BMI, BW, DTT |
| 68 |
2013 |
Conservative management of an elderly patient with Eisenmenger syndrome. |
IPAH |
| 69 |
2013 |
Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study). |
QOL, RV |
| 70 |
2013 |
Inflammatory markers are elevated in Eisenmenger syndrome. |
hs-CRP, IFN-gamma, IL-2, WHO |
| 71 |
2013 |
Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease. |
6MWD, PAH |
| 72 |
2013 |
Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. |
--- |
| 73 |
2013 |
[General anesthesia for a patient with Eisenmenger syndrome: a case report]. |
--- |
| 74 |
2012 |
Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome. |
BNP |
| 75 |
2012 |
Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome. |
6MWD, Ea, MPI, PASP, RV, WHO |
| 76 |
2012 |
Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome. |
BNP, CI |
| 77 |
2012 |
[Clinical and hemodynamic features of Eisenmenger syndrome patients at the time of first admission: a tertiary referral-center experience]. |
VSD |
| 78 |
2011 |
Ambrisentan for pulmonary arterial hypertension due to congenital heart disease. |
--- |
| 79 |
2011 |
Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study. |
6MWD, EPBF, PDE5, PVR, SVR, WHO |
| 80 |
2011 |
Exercise performance and quality of life is more impaired in Eisenmenger syndrome than in complex cyanotic congenital heart disease with pulmonary stenosis. |
PS |
| 81 |
2011 |
Experience of managing pregnant women with Eisenmenger's syndrome: maternal and fetal outcome in 13 cases. |
--- |
| 82 |
2011 |
Iron deficiency is associated with adverse outcome in Eisenmenger patients. |
MCH, MCV, NYHA |
| 83 |
2011 |
Massive epistaxis in a patient with Eisenmenger syndrome: illustrating the clot-versus-bleed conundrum. |
--- |
| 84 |
2011 |
Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy. |
NYHA, QOL |
| 85 |
2011 |
The outcome of Eisenmenger patients with trisomy 21 does not differ from patients without trisomy 21. |
--- |
| 86 |
2011 |
Use of moderate sedation for a patient with Down syndrome, intellectual disability, and Eisenmenger syndrome: a case report. |
DS, ID |
| 87 |
2010 |
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. |
ASD, ASD, mPAP, PVRI, VSD |
| 88 |
2010 |
Right ventricular function in adult patients with Eisenmenger physiology: insights from quantitative echocardiography. |
PAH, PASP, RV |
| 89 |
2010 |
[Pulmonary arterial hypertension in adult patients with congenital heart disease]. |
CHD, PAH, PAPm, PH, PVR |
| 90 |
2009 |
Cardiac decompensation in a patient with Eisenmenger syndrome undergoing T5-T7 levels laminectomy in the sitting position. |
ICU |
| 91 |
2009 |
Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. |
PAH |
| 92 |
2009 |
Eisenmenger syndrome and juvenile rheumatoid arthritis--a case of double diagnosis. |
--- |
| 93 |
2009 |
Pulmonary arterial hypertension in congenital heart diseases. |
CHDs |
| 94 |
2009 |
The Belgian Eisenmenger syndrome registry: implications for treatment strategies? |
CHD, PAH |
| 95 |
2008 |
Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. |
BMPR-2, IPAH, TGF |
| 96 |
2007 |
[Lung and heart-lung transplantation for Eisenmenger syndrome: report of 5 cases]. |
HLT, SLT |
| 97 |
2006 |
Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome. |
--- |
| 98 |
2006 |
Multiple variables affecting blood usage in lung transplantation. |
CF, CPB, FFP, PLT, RBC |
| 99 |
2006 |
[Clinical implications and prognostic significance of the study on the circadian variation of heart rate variability in patients with severe pulmonary hypertension]. |
HRV, PPH |
| 100 |
2005 |
General anaesthesia for emergency caesarian section in a patient with Eisenmenger's syndrome and pre-eclampsia. |
--- |
A Search Service for Abbreviation / Long Form
